Suppr超能文献

《SIR-Spheres 术后研究(P4S)》:先前接受钇 90 树脂微球选择性内部放射治疗的肝切除或肝移植患者的安全性回顾性分析。

The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.

机构信息

HPB and Transplant Surgery, Clinica Universidad de Navarra, IDISNA, Pamplona, Navarra, Spain.

Liver Unit, Clinica Universidad de Navarra, IDISNA, CIBEREHD, Pamplona, Navarra, Spain.

出版信息

Ann Surg Oncol. 2017 Sep;24(9):2465-2473. doi: 10.1245/s10434-017-5950-z. Epub 2017 Jun 26.

Abstract

BACKGROUND

Reports show that selective internal radiation therapy (SIRT) may downsize inoperable liver tumors to resection or transplantation, or enable a bridge-to-transplant. A small-cohort study found that long-term survival in patients undergoing resection following SIRT appears possible but no robust studies on postsurgical safety outcomes exist. The Post-SIR-Spheres Surgery Study was an international, multicenter, retrospective study to assess safety outcomes of liver resection or transplantation following SIRT with yttrium-90 (Y-90) resin microspheres (SIR-Spheres; Sirtex).

METHODS

Data were captured retrospectively at participating SIRT centers, with Y-90 resin microspheres, surgery (resection or transplantation), and follow-up for all eligible patients. Primary endpoints were perioperative and 90-day postoperative morbidity and mortality. Standard statistical methods were used.

RESULTS

The study included 100 patients [hepatocellular carcinoma: 49; metastatic colorectal cancer (mCRC): 30; cholangiocarcinoma, metastatic neuroendocrine tumor, other: 7 each]; 36% of patients had one or more lines of chemotherapy pre-SIRT. Sixty-three percent of patients had comorbidities, including hypertension (44%), diabetes (26%), and cardiopathy (16%). Post-SIRT, 71 patients were resected and 29 received a liver transplant. Grade 3+ peri/postoperative complications and any grade of liver failure were experienced by 24 and 7% of patients, respectively. Four patients died <90 days postsurgery; all were trisectionectomies (mCRC: 3; cholangiocarcinoma: 1) and typically had one or more previous chemotherapy lines and presurgical comorbidities.

CONCLUSIONS

In 100 patients undergoing liver surgery after receiving SIRT, mortality and complication rates appeared acceptable given the risk profile of the recruited patients.

摘要

背景

有报道称,选择性内部放射治疗(SIRT)可能使无法手术的肝肿瘤缩小到可切除或可移植的程度,或者为移植提供桥接。一项小样本研究发现,接受 SIRT 后行切除术的患者长期生存似乎是可能的,但尚无关于术后安全性结果的稳健研究。SIR-Spheres 手术后研究是一项国际性、多中心、回顾性研究,旨在评估钇-90(Y-90)树脂微球(SIR-Spheres;Sirtex)SIRT 后行肝切除或移植的安全性结果。

方法

在参与 SIRT 的中心,通过回顾性收集数据,对所有符合条件的患者进行 Y-90 树脂微球、手术(切除或移植)和随访。主要终点为围手术期和术后 90 天的发病率和死亡率。采用标准统计方法。

结果

该研究纳入 100 例患者[肝细胞癌:49 例;转移性结直肠癌(mCRC):30 例;胆管癌、转移性神经内分泌肿瘤、其他:各 7 例];36%的患者在 SIRT 前接受了一线或多线化疗。63%的患者合并有疾病,包括高血压(44%)、糖尿病(26%)和心脏病(16%)。SIRT 后,71 例患者接受了切除术,29 例患者接受了肝移植。分别有 24%和 7%的患者出现 3+级围手术期/术后并发症和任何级别的肝功能衰竭。4 例患者术后 90 天内死亡;均为三叶切除术(mCRC:3 例;胆管癌:1 例),且通常有 1 次或更多次先前的化疗和术前合并症。

结论

在 100 例接受 SIRT 后行肝切除术的患者中,考虑到招募患者的风险状况,死亡率和并发症发生率似乎可以接受。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验